Stock Events

Stock Events

Search...

Brainstorm Cell Therapeutics (BCLI) Q4 2022 Earnings

30MarConfirmed

May 22

Aug 22

Nov 22

Q4 2022

-0.19

-0.17

-0.15

-0.13

Details

Expected EPS

-0.14

Actual EPS

-0.13

Surprise EPS

0.01

Surprise Percent

+7.14%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of -0.13 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.